ICER collaborators and staff had findings on the cost-effectiveness of PCSK9 inhibitors for treatment of high cholesterol published in JAMA. Download the publication here (subscription required for full text).
ICER collaborators and staff had findings on the cost-effectiveness of PCSK9 inhibitors for treatment of high cholesterol published in JAMA. Download the publication here (subscription required for full text).